What is the hypothalamic-pituitary-gonadal (HPG) axis?
The HPG axis is a feedback loop between the brain and testes that regulates testosterone production; TRT suppresses this axis by reducing signals that normally trigger natural testosterone synthesis.
The hypothalamic-pituitary-gonadal axis is a three-part endocrine feedback system controlling testosterone production in males. The hypothalamus releases gonadotropin-releasing hormone (GnRH), which signals the pituitary gland to produce luteinizing hormone (LH) and follicle-stimulating hormone (FSH). These hormones then stimulate the testes to produce testosterone and sperm.
This system operates as a negative feedback loop. When testosterone levels rise, the brain registers this signal and reduces GnRH, LH, and FSH production, naturally limiting testosterone output. This balance maintains the body's optimal hormonal state.
Testosterone replacement therapy fundamentally disrupts this loop. External testosterone enters the bloodstream, and the hypothalamus detects adequate or excess levels. In response, it suppresses GnRH signaling, which shuts down the pituitary's production of LH and FSH. Without these stimulating hormones, the testes reduce or halt their own testosterone production and sperm manufacturing. The longer TRT continues, the more the endogenous system can atrophy.
This suppression is why men on TRT typically cannot restart natural hormone production immediately after stopping therapy. Recovery requires time for the HPG axis to reactivate and resume its normal regulatory function. Clinicians offering hormone therapy monitor this axis through blood work to assess how treatment affects natural production capacity.